| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.988 | 0 | 0.993 | Angiotensin AT1 receptor antagonist | 0.981 0 DBMET00009 0.3 0.001 DBMET00010 0.993 0 DBMET00303 | DBMET00303 | |
| 0.985 | 0.001 | 0.985 | Angiotensin AT2 receptor antagonist | 0.798 0.001 DBMET00009 0.318 0.002 DBMET00010 0.697 0.001 DBMET00303 | ||
| 0.984 | 0 | 0.99 | Angiotensin II receptor antagonist | 0.976 0 DBMET00009 0.317 0.001 DBMET00010 0.99 0 DBMET00303 | DBMET00303 | |
| 0.98 | 0 | 0.98 | Angiotensin AT1B receptor antagonist | 0.462 0.001 DBMET00009 0.061 0.002 DBMET00010 0.67 0 DBMET00303 | ||
| 0.954 | 0.001 | 0.954 | Angiotensin AT1A receptor antagonist | 0.692 0.001 DBMET00009 0.247 0.002 DBMET00010 0.615 0.001 DBMET00303 | ||
| 0.501 | 0.032 | 0.702 | 5 Hydroxytryptamine release inhibitor | 0.432 0.06 DBMET00009 0.702 0.004 DBMET00303 | DBMET00303 | |
| 0.495 | 0.031 | 0.616 | Histamine release inhibitor | 0.338 0.105 DBMET00009 0.616 0.009 DBMET00303 | DBMET00303 | |
| 0.46 | 0.004 | 0.668 | NADPH oxidase inhibitor | 0.389 0.005 DBMET00009 0.668 0.003 DBMET00303 | DBMET00303 | |
| 0.477 | 0.037 | 0.477 | Calcium channel L-type activator | 0.397 0.083 DBMET00010 | ||
| 0.453 | 0.02 | 0.737 | Cardiotonic | 0.737 0.005 DBMET00009 0.289 0.061 DBMET00010 0.685 0.005 DBMET00303 | DBMET00009 | |
| 0.389 | 0.003 | 0.389 | Phosphodiesterase 7B inhibitor | 0.105 0.05 DBMET00009 0.084 0.079 DBMET00010 0.117 0.04 DBMET00303 | ||
| 0.258 | 0.005 | 0.258 | Phosphodiesterase 3A inhibitor | 0.133 0.019 DBMET00009 0.135 0.018 DBMET00303 | ||
| 0.248 | 0.008 | 0.373 | Alcohol dehydrogenase inhibitor | 0.193 0.013 DBMET00009 0.373 0.004 DBMET00303 | DBMET00303 | |
| 0.239 | 0.014 | 0.239 | Catenin beta inhibitor | |||
| 0.178 | 0.004 | 0.178 | Leukotriene D4 antagonist | 0.031 0.015 DBMET00009 0.054 0.009 DBMET00303 | ||
| 0.172 | 0.009 | 0.172 | Peroxisome proliferator-activated receptor gamma agonist | 0.108 0.024 DBMET00009 0.066 0.052 DBMET00010 0.154 0.012 DBMET00303 | ||
| 0.148 | 0.005 | 0.148 | Glutamate (mGluR group II) agonist | 0.03 0.029 DBMET00303 | ||
| 0.141 | 0.005 | 0.141 | Glutamate (mGluR2) agonist | |||
| 0.193 | 0.062 | 0.417 | Growth hormone agonist | 0.41 0.014 DBMET00009 0.13 0.107 DBMET00010 0.417 0.014 DBMET00303 | DBMET00303 | |
| 0.14 | 0.01 | 0.14 | Sphingosine 1-phosphate receptor 4 agonist | 0.096 0.027 DBMET00009 | ||
| 0.122 | 0.005 | 0.122 | Sphingosine kinase 2 inhibitor | |||
| 0.107 | 0.005 | 0.149 | Nicotinic acid receptor 2 agonist | 0.091 0.006 DBMET00009 0.149 0.004 DBMET00303 | DBMET00303 | |
| 0.158 | 0.059 | 0.167 | Hemostatic | 0.167 0.051 DBMET00303 | DBMET00303 | |
| 0.108 | 0.01 | 0.108 | Bombesin 3 receptor antagonist | |||
| 0.095 | 0.005 | 0.095 | Glutamate (mGluR group II) antagonist | |||
| 0.119 | 0.038 | 0.412 | Uric acid excretion stimulant | 0.188 0.015 DBMET00009 0.147 0.024 DBMET00010 0.412 0.004 DBMET00303 | DBMET00303 | |
| 0.106 | 0.033 | 0.106 | Glutamate receptor agonist | |||
| 0.077 | 0.005 | 0.077 | Glutamate (mGluR2) antagonist | |||
| 0.084 | 0.014 | 0.084 | Sphingosine kinase inhibitor | |||
| 0.092 | 0.026 | 0.092 | Glutamate (mGluR) agonist | |||
| 0.089 | 0.028 | 0.089 | Phosphodiesterase III inhibitor | |||
| 0.084 | 0.029 | 0.092 | Leukotriene antagonist | 0.092 0.025 DBMET00303 | DBMET00303 | |
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 4C inhibitor | |||
| 0.069 | 0.015 | 0.069 | Leukotriene C antagonist | 0.058 0.033 DBMET00303 | ||
| 0.055 | 0.01 | 0.055 | AMPA 2 receptor antagonist | |||
| 0.051 | 0.014 | 0.134 | Nicotinic acid receptor agonist | 0.057 0.012 DBMET00009 0.134 0.004 DBMET00303 | DBMET00303 | |
| 0.065 | 0.032 | 0.065 | Phosphodiesterase 1A inhibitor | |||
| 0.046 | 0.014 | 0.046 | Leukotriene C4 antagonist | 0.037 0.034 DBMET00303 | ||
| 0.053 | 0.023 | 0.053 | Phosphodiesterase 3B inhibitor | |||
| 0.079 | 0.048 | 0.079 | Phosphodiesterase 4D inhibitor | |||
| 0.066 | 0.036 | 0.066 | Phosphodiesterase 1C inhibitor | |||
| 0.047 | 0.019 | 0.047 | Growth hormone secretagogue receptor antagonist | |||
| 0.067 | 0.039 | 0.067 | Phosphodiesterase VII inhibitor | |||
| 0.073 | 0.047 | 0.073 | Phosphodiesterase VIII inhibitor | 0.066 0.064 DBMET00009 | ||
| 0.058 | 0.033 | 0.086 | Prostaglandin antagonist | 0.086 0.021 DBMET00303 | DBMET00303 | |
| 0.053 | 0.034 | 0.053 | Carbonic anhydrase II stimulant | |||
| 0.023 | 0.014 | 0.026 | Bombesin agonist | 0.026 0.01 DBMET00303 | DBMET00303 | |
| 0.02 | 0.012 | 0.023 | Bombesin 3 receptor agonist | 0.023 0.009 DBMET00303 | DBMET00303 | |
| 0.034 | 0.031 | 0.034 | Carbonic anhydrase I stimulant | |||
| 0.037 | 0.034 | 0.037 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.022 | 0.029 | 0.05 | Nicotinic acid receptor 2 antagonist | 0.05 0.004 DBMET00303 | DBMET00303 | |
| 0.033 | 0.04 | 0.054 | Factor XIa inhibitor | 0.054 0.016 DBMET00303 | DBMET00303 | |
| 0.061 | 0.074 | 0.095 | Glutamate (mGluR) antagonist | 0.095 0.038 DBMET00010 | DBMET00010 | |
| 0.02 | 0.033 | 0.03 | Endothelin receptor antagonist | 0.03 0.018 DBMET00303 | DBMET00303 | |
| 0.051 | 0.066 | 0.081 | Prostaglandin F2 alpha antagonist | 0.056 0.054 DBMET00009 0.081 0.021 DBMET00303 | DBMET00303 | |
| 0.088 | 0.113 | 0.099 | Glutamate receptor antagonist | 0.099 0.098 DBMET00010 | DBMET00010 | |
| 0.029 | 0.059 | 0.048 | Oleamide hydrolase inhibitor | 0.048 0.029 DBMET00009 | DBMET00009 | |
| 0.024 | 0.06 | 0.434 | Urate transporter 1 inhibitor | 0.078 0.008 DBMET00009 0.434 0.002 DBMET00303 | DBMET00303 | |
| 0.022 | 0.067 | 0.032 | Factor XI inhibitor | 0.032 0.026 DBMET00303 | DBMET00303 | |
| 0.061 | 0.109 | 0.076 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.071 DBMET00303 | DBMET00303 | |
| 0.071 | 0.123 | 0.173 | Xanthine oxidase inhibitor | 0.137 0.04 DBMET00009 0.173 0.026 DBMET00303 | DBMET00303 | |
| 0.014 | 0.072 | 0.036 | Growth hormone releasing factor agonist | 0.036 0.021 DBMET00009 0.031 0.025 DBMET00303 | DBMET00009 | |
| 0.005 | 0.063 | 0.023 | Kainate receptor 1 antagonist | 0.023 0.014 DBMET00303 | DBMET00303 | |
| 0.022 | 0.085 | 0.062 | Adenosine deaminase inhibitor | 0.062 0.019 DBMET00010 | DBMET00010 | |
| 0.007 | 0.08 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 DBMET00303 | DBMET00303 | |
| 0.02 | 0.133 | 0.059 | Acid-sensing ion channel blocker | 0.056 0.012 DBMET00009 0.059 0.01 DBMET00303 | DBMET00303 | |
| 0.057 | 0.174 | 0.181 | DNA polymerase I inhibitor | 0.181 0.035 DBMET00010 | DBMET00010 | |
| 0.02 | 0.139 | 0.049 | Nicotinic acid receptor 1 agonist | 0.049 0.021 DBMET00303 | DBMET00303 | |
| 0.148 | 0.302 | 0.229 | Interleukin 2 agonist | 0.229 0.144 DBMET00010 | DBMET00010 | |
| 0.041 | 0.198 | 0.271 | Mediator release inhibitor | 0.096 0.075 DBMET00009 0.271 0.008 DBMET00303 | DBMET00303 | |
| 0.067 | 0.243 | 0.201 | Diuretic | 0.201 0.044 DBMET00303 | DBMET00303 | |
| 0.034 | 0.215 | 0.098 | Potassium channel large-conductance Ca-activated activator | 0.098 0.025 DBMET00303 | DBMET00303 | |
| 0.022 | 0.213 | 0.075 | Leukotriene synthesis inhibitor | 0.075 0.04 DBMET00303 | DBMET00303 | |
| 0.06 | 0.274 | 0.134 | Phospholipase A2 inhibitor | 0.134 0.095 DBMET00303 | DBMET00303 | |
| 0.005 | 0.245 | 0.029 | Adenosine A1 receptor agonist | 0.029 0.012 DBMET00010 | DBMET00010 | |
| 0.13 | 0.402 | 0.622 | Cyclophilin D inhibitor | 0.622 0.024 DBMET00010 0.373 0.107 DBMET00303 | DBMET00010 | |
| 0.058 | 0.332 | 0.199 | Platelet antagonist | 0.172 0.124 DBMET00010 0.199 0.101 DBMET00303 | DBMET00303 | |
| 0.012 | 0.314 | 0.083 | Maillard reaction inhibitor | 0.083 0.024 DBMET00303 | DBMET00303 | |
| 0.063 | 0.392 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.127 0.125 DBMET00303 | DBMET00303 | |
| 0.009 | 0.404 | 0.049 | Plasminogen activator inhibitor antagonist | 0.049 0.034 DBMET00303 | DBMET00303 | |
| 0.004 | 0.399 | 0.024 | Sodium/glucose cotransporter 2 inhibitor | 0.024 0.022 DBMET00010 | DBMET00010 | |
| 0.015 | 0.433 | 0.063 | Glutamate (mGluR group I) antagonist | 0.063 0.06 DBMET00010 | DBMET00010 | |
| 0.057 | 0.489 | 0.177 | Hypoglycemic | 0.177 0.138 DBMET00010 | DBMET00010 | |
| 0.005 | 0.444 | 0.053 | Glutamate (mGluR5) antagonist | 0.053 0.027 DBMET00010 | DBMET00010 | |
| 0.024 | 0.508 | 0.186 | Immunostimulant | 0.186 0.129 DBMET00010 | DBMET00010 | |
| 0.017 | 0.568 | 0.101 | Breast cancer-resistant protein inhibitor | 0.101 0.054 DBMET00010 | DBMET00010 | |
| 0.038 | 0.622 | 0.218 | Gastrin inhibitor | 0.218 0.122 DBMET00303 | DBMET00303 | |
| 0.015 | 0.607 | 0.118 | Thrombolytic | 0.118 0.113 DBMET00303 | DBMET00303 | |
| 0.017 | 0.61 | 0.194 | Angiogenesis stimulant | 0.194 0.098 DBMET00010 | DBMET00010 | |
| 0.033 | 0.64 | 0.14 | Hepatoprotectant | 0.14 0.121 DBMET00010 | DBMET00010 | |
| 0.037 | 0.658 | 0.199 | Vasodilator, coronary | 0.199 0.183 DBMET00010 | DBMET00010 | |
| 0.004 | 0.63 | 0.062 | Fibroblast growth factor 4 antagonist | 0.062 0.035 DBMET00009 | DBMET00009 | |
| 0.06 | 0.818 | 0.249 | Peptidyltransferase inhibitor | 0.249 0.051 DBMET00010 | DBMET00010 | |
| 0.006 | 0.855 | 0.311 | Antibacterial | 0.311 0.127 DBMET00010 | DBMET00010 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |